Sarepta Therapeutics, Inc. (SRPT) on GreekSoup https://greeksoup.ai/stocks/us/srpt/ Every dated entry in the public record on Sarepta Therapeutics, Inc.: results, filings, insider trades and the rest, from the filings, the last 90 days. en Mon, 12 Oct 2026 00:00:00 +0000 Sarepta Therapeutics, Inc.: short interest 22,784,187 shares at the 30 September 2026 settlement, 8.62 days to coverhttps://greeksoup.ai/stocks/us/srpt/short-interest/us:SRPT:short-interest:2026-09-30:194ae25ad6Wed, 30 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc. filed 8-K: material agreementhttps://greeksoup.ai/stocks/us/srpt/filings/us:SRPT:filing:2026-09-23:cd57ce8d12Wed, 23 Sep 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc.: short interest 25,434,681 shares at the 15 September 2026 settlement, 8.02 days to coverhttps://greeksoup.ai/stocks/us/srpt/short-interest/us:SRPT:short-interest:2026-09-15:6678ac54b8Tue, 15 Sep 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc.: short interest 24,621,090 shares at the 31 August 2026 settlement, 8.46 days to coverhttps://greeksoup.ai/stocks/us/srpt/short-interest/us:SRPT:short-interest:2026-08-31:e7b257d250Mon, 31 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc.: short interest 27,049,885 shares at the 14 August 2026 settlement, 9.07 days to coverhttps://greeksoup.ai/stocks/us/srpt/short-interest/us:SRPT:short-interest:2026-08-14:872f7d8c4bFri, 14 Aug 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc.: Schedule 13G/A filed by AQR Capital Management, LLC, 5.0% of the classhttps://greeksoup.ai/stocks/us/srpt/holders/us:SRPT:schedule-13:2026-08-13:84a77d190aThu, 13 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc.: Schedule 13G filed by STATE STREET CORPORATION, 8.4% of the classhttps://greeksoup.ai/stocks/us/srpt/holders/us:SRPT:schedule-13:2026-08-07:c685585693Fri, 07 Aug 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc. Q2 FY2026 results: revenue $401 million, net income -$5 millionhttps://greeksoup.ai/stocks/us/srpt/results/fy2026-q2/us:SRPT:result:2026-08-05:a4b2e5de11Wed, 05 Aug 2026 00:00:00 +0000ResultsResults. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc. filed 8-K: results of operationshttps://greeksoup.ai/stocks/us/srpt/filings/us:SRPT:filing:2026-08-05:cc38743620Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc. filed 10-Q: 10-qhttps://greeksoup.ai/stocks/us/srpt/filings/us:SRPT:filing:2026-08-05:1168d9faf2Wed, 05 Aug 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc.: Schedule 13G/A filed by Vanguard Portfolio Management, 8.1% of the classhttps://greeksoup.ai/stocks/us/srpt/holders/us:SRPT:schedule-13:2026-07-31:258c97eb49Fri, 31 Jul 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc.: short interest 27,566,969 shares at the 31 July 2026 settlement, 8.77 days to coverhttps://greeksoup.ai/stocks/us/srpt/short-interest/us:SRPT:short-interest:2026-07-31:faccbbcf2eFri, 31 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc.: Schedule 13G/A filed by BlackRock, Inc., 15.8% of the classhttps://greeksoup.ai/stocks/us/srpt/holders/us:SRPT:schedule-13:2026-07-30:7f3ba70de1Thu, 30 Jul 2026 00:00:00 +0000Schedule 13D/13GSchedule 13D/13G. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc. filed S-8: s-8https://greeksoup.ai/stocks/us/srpt/filings/us:SRPT:filing:2026-07-28:baf3d952e6Tue, 28 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc. filed 8-K: officer or director change, regulation fd disclosurehttps://greeksoup.ai/stocks/us/srpt/filings/us:SRPT:filing:2026-07-27:6536243837Mon, 27 Jul 2026 00:00:00 +0000SEC filingSEC filing. The filing. The page on GreekSoup.

]]> Sarepta Therapeutics, Inc.: short interest 28,489,470 shares at the 15 July 2026 settlement, 9.22 days to coverhttps://greeksoup.ai/stocks/us/srpt/short-interest/us:SRPT:short-interest:2026-07-15:43bab0943cWed, 15 Jul 2026 00:00:00 +0000Short interestShort interest. The filing. The page on GreekSoup.

]]>